The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s HPV associated disorders market report forecasts the HPV associated disorders market size to grow to $24.77 Billion by 2027, with a CAGR (compound annual growth rate) of more than 6%.

Learn More On The HPV Associated Disorders Market Report 2023 – https://www.thebusinessresearchcompany.com/report/hpv-associated-disorders-global-market-report

HPV Associated Disorders Market Size Forecast
The global HPV associated disorders market is expected to grow from $17.82 billion in 2022 to $19.07 billion in 2023 at a compound annual growth rate (CAGR) of 7.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The HPV associated disorders market size is expected to grow to $24.77 billion in 2027 at a CAGR of 6.7%.

North America held the largest HPV associated disorders market share, and Asia-Pacific was the fastest-growing region in 2022.

Key HPV Associated Disorders Market Driver ­– Increase In The Prevalence Of HPV-Related Cases
For instance, In January 2022, In 2020, according to a report published by cancer.net, an estimated 14,100 women in the United States will be diagnosed with invasive cervical cancer, with 604,127 women worldwide diagnosed with cervical cancer. Furthermore, In 2020, an estimated 341,831 women died from cervical cancer worldwide. Therefore, an increase in the prevalence of HPV cases will drive the HPV-associated disorders market.

Request for A Sample Of The Global HPV Associated Disorders Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7777&type=smp

Key HPV Associated Disorders Market Trend – Adopting Targeted Therapies
Major players are developing and adopting targeted therapies for treating HPV-associated disorders such as cervical cancer, oropharyngeal cancer, and others. Targeted therapies include drugs that target vascular endothelial growth factor protein and tissue-factor (TF) protein on cancer cells and others. For instance, in September 2021, FDA approved Genmab A/S and Seagen Inc., drug Tivdak (tisotumab vedotin-tftv) for recurrent or metastatic cervical cancer with disease progression on or after chemotherapy. Thus, emerging targeted therapies will treat HPV-associated disorders effectively.

HPV Associated Disorders Market Segment
1) By Indication: Cervical Intraepithelial Neoplasia (CIN), Cervical Cancer, Anal Intraepithelial Neoplasia (AIN), Anal Cancer, Genital Warts, Other Indications
2) By Therapy: Prevention, Treatment
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

HPV Associated Disorders Market Major Players and Strategies
Major players in the HPV associated disorders market are AstraZeneca plc, F. Hoffmann-La Roche Ltd., Biocon Ltd., GlaxoSmithKline plc, Merck & Co. Inc., Eli Lilly and Company, Cytovation AS, Pfizer Inc., Amgen Inc., Johnson & Johnson Services Inc., Advaxis Inc., Kino Pharma Inc., Serum Institute, Inovio Pharmaceuticals and PapiVax Biotech Inc.

In May 2022, GlaxoSmithKline plc, a UK-based biopharma company acquired, Affinivax, Inc for $2.1 billion. Through this acquisition, GSK plc strengthens its vaccine R&D pipeline and provides access to a new technology MAPS (Multiple Antigen Presenting System). Affinivax, Inc is a US-based clinical stage biopharmaceutical company that provides next-generation vaccine technology platforms for the development of vaccines.

The HPV Associated Disorders Global Market Report 2023 covers regional data on HPV associated disorders market size, HPV associated disorders market trends and drivers, opportunities, strategies, and HPV associated disorders market competitor analysis. The countries covered in the HPV associated disorders market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The human papillomavirus-associated disorders refer to a virus that can induce aberrant tissue growth such as warts and other cell abnormalities. These disorders are mainly transmitted by sexual intercourse or other forms of skin-to-skin contact. Vaccines, medication, and other diagnoses can help protect against HPV types that cure HPV cancer.

View More Reports Related To The HPV Associated Disorders Market –
Bleeding Disorders Treatment Global Market Report 2023
Dermatitis Global Market Report 2023
Metabolomics Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: